Skip to main content

UNITEDHEALTH GROUP INC

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

UNH$405.12+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Operations

For the Years Ended December 31,
(in millions, except per share data)202320222021
Revenues:
Premiums$290,827$257,157$226,233
Products42,58337,42434,437
Services34,12327,55124,603
Investment and other income4,0892,0302,324
Total revenues371,622324,162287,597
Operating costs:
Medical costs241,894210,842186,911
Operating costs54,62847,78242,579
Cost of products sold38,77033,70331,034
Depreciation and amortization3,9723,4003,103
Total operating costs339,264295,727263,627
Earnings from operations32,35828,43523,970
Interest expense(3,246)(2,092)(1,660)
Earnings before income taxes29,11226,34322,310
Provision for income taxes(5,968)(5,704)(4,578)
Net earnings23,14420,63917,732
Earnings attributable to noncontrolling interests(763)(519)(447)
Net earnings attributable to UnitedHealth Group common shareholders$22,381$20,120$17,285
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic$24.12$21.47$18.33
Diluted$23.86$21.18$18.08
Basic weighted-average number of common shares outstanding928937943
Dilutive effect of common share equivalents101313
Diluted weighted-average number of common shares outstanding938950956
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents631
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.